Hisamitsu Pharmaceutical Co., Inc.
HTSUF · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Market Cap | $272 | $299 | $332 | $327 |
| - Cash | $115 | $112 | $122 | $129 |
| + Debt | $4 | $2 | $2 | $2 |
| Enterprise Value | $162 | $188 | $213 | $200 |
| Revenue | $156 | $142 | $128 | $120 |
| % Growth | 10.1% | 10.4% | 6.8% | – |
| Gross Profit | $91 | $79 | $73 | $70 |
| % Margin | 58.5% | 55.7% | 56.7% | 58.3% |
| EBITDA | $35 | $24 | $17 | $17 |
| % Margin | 22.5% | 17.2% | 12.9% | 14.4% |
| Net Income | $22 | $14 | $12 | $10 |
| % Margin | 13.9% | 9.9% | 9.1% | 8% |
| EPS Diluted | 295.15 | 181.42 | 147.87 | 118.84 |
| % Growth | 62.7% | 22.7% | 24.4% | – |
| Operating Cash Flow | $19 | $18 | $13 | $19 |
| Capital Expenditures | -$14 | -$13 | -$8 | -$4 |
| Free Cash Flow | $5 | $5 | $5 | $15 |